Conditional survival in patients treated with vascular endothelial growth factor-targeted therapy for advanced renal cell carcinoma

被引：0
|
作者：
Y. Zhu
Y. P. Hong
H. L. Zhang
G. H. Shi
W. J. Xiao
Z. H. Wang
X. D. Yao
S. L. Zhang
B. Dai
D. W. Ye
机构：
[1] Fudan University Shanghai Cancer Center,Department of Urology
[2] Fudan University Shanghai Cancer Center,Department of Medical Oncology
[3] Fudan University,Department of Oncology, Shanghai Medical College
来源：
Journal of Cancer Research and Clinical Oncology | 2012年 / 138卷
关键词：
Molecular targeted therapy; Multivariate analysis; Prognosis; Renal cell carcinoma; Survival analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1901 / 1907
页数：6
相关论文
共 50 条
  • [1] Conditional survival in patients treated with vascular endothelial growth factor-targeted therapy for advanced renal cell carcinoma
    Zhu, Y.
    Hong, Y. P.
    Zhang, H. L.
    Shi, G. H.
    Xiao, W. J.
    Wang, Z. H.
    Yao, X. D.
    Zhang, S. L.
    Dai, B.
    Ye, D. W.
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (11) : 1901 - 1907
  • [2] Metastatic Sarcomatoid Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor-Targeted Therapy
    Golshayan, Ali Reza
    George, Saby
    Heng, Daniel Y.
    Elson, Paul
    Wood, Laura S.
    Mekhail, Tarek M.
    Garcia, Jorge A.
    Aydin, Hakan
    Zhou, Ming
    Bukowski, Ronald M.
    Rini, Brian I.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (02) : 235 - 241
  • [3] Vascular Endothelial Growth Factor-Targeted Therapies in Advanced Renal Cell Carcinoma
    Albiges, Laurence
    Salem, Mohamed
    Rini, Brian
    Escudier, Bernard
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2011, 25 (04) : 813 - +
  • [4] Vascular Endothelial Growth Factor-targeted Therapy in Metastatic Renal Cell Carcinoma
    Rini, Brian I.
    [J]. CANCER, 2009, 115 (10) : 2306 - 2312
  • [5] Vascular Endothelial Growth Factor-Targeted Therapy for the Treatment of Renal Cell Carcinoma
    Escudier, Bernard
    Albiges, Laurence
    [J]. DRUGS, 2011, 71 (09) : 1179 - 1191
  • [6] Vascular Endothelial Growth Factor-Targeted Therapy for the Treatment of Renal Cell Carcinoma
    Bernard Escudier
    Laurence Albiges
    [J]. Drugs, 2011, 71 : 1179 - 1191
  • [7] The impact of kidney function on the outcome of metastatic renal cell carcinoma patients treated with vascular endothelial growth factor-targeted therapy
    Macfarlane, Robyn
    Heng, Daniel Y. C.
    Xie, Wanling
    Knox, Jennifer J.
    McDermott, David F.
    Rini, Brian I.
    Kollmannsberger, Christian
    Choueiri, Toni K.
    [J]. CANCER, 2012, 118 (02) : 365 - 370
  • [8] Does Obesity Influence the Prognosis of Metastatic Renal Cell Carcinoma in Patients Treated with Vascular Endothelial Growth Factor-Targeted Therapy?
    Steffens, Sandra
    Gruenwald, Viktor
    Ringe, Kristina I.
    Seidel, Christoph
    Eggers, Hendrik
    Schrader, Mark
    Wacker, Frank
    Kuczyk, Markus A.
    Schrader, Andres J.
    [J]. ONCOLOGIST, 2011, 16 (11): : 1565 - 1571
  • [9] Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma
    Rini, BI
    Small, EJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (05) : 1028 - 1043
  • [10] Prognostic Biomarkers for Response to Vascular Endothelial Growth Factor-Targeted Therapy for Renal Cell Carcinoma
    Winer, Andrew G.
    Motzer, Robert J.
    Hakimi, A. Ari
    [J]. UROLOGIC CLINICS OF NORTH AMERICA, 2016, 43 (01) : 95 - +
12345